Kenvue Inc. (NYSE:KVUE) Shares Purchased by Focus Partners Wealth

Focus Partners Wealth grew its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 18.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,564,568 shares of the company's stock after acquiring an additional 239,712 shares during the quarter. Focus Partners Wealth owned about 0.08% of Kenvue worth $33,404,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Grove Bank & Trust lifted its stake in shares of Kenvue by 438.4% during the 4th quarter. Grove Bank & Trust now owns 1,163 shares of the company's stock worth $25,000 after purchasing an additional 947 shares during the period. Geneos Wealth Management Inc. acquired a new position in Kenvue in the fourth quarter valued at $29,000. SRS Capital Advisors Inc. lifted its position in Kenvue by 67.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after buying an additional 571 shares during the period. Fortitude Family Office LLC boosted its stake in Kenvue by 106.6% in the 4th quarter. Fortitude Family Office LLC now owns 1,506 shares of the company's stock worth $32,000 after buying an additional 777 shares during the last quarter. Finally, Asset Planning Inc purchased a new stake in Kenvue in the 4th quarter valued at about $42,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Royal Bank of Canada reiterated a "sector perform" rating and set a $24.00 price objective on shares of Kenvue in a report on Monday, February 3rd. Canaccord Genuity Group increased their price target on shares of Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a research note on Wednesday, March 5th. Barclays boosted their price objective on shares of Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a research note on Monday. Evercore ISI assumed coverage on Kenvue in a report on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price on the stock. Finally, Redburn Atlantic began coverage on Kenvue in a research note on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price objective on the stock. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Kenvue has a consensus rating of "Hold" and an average price target of $25.33.

Kenvue Stock Up 0.9%

Shares of NYSE KVUE traded up $0.22 during trading on Friday, reaching $24.10. 6,261,377 shares of the stock were exchanged, compared to its average volume of 16,714,263. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $25.17. The company has a market capitalization of $46.23 billion, a price-to-earnings ratio of 45.46, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The business's 50-day moving average price is $23.15 and its 200 day moving average price is $22.58.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. The firm had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. During the same quarter in the prior year, the business posted $0.28 earnings per share. Kenvue's revenue for the quarter was down 3.9% on a year-over-year basis. As a group, equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th will be issued a $0.205 dividend. The ex-dividend date is Wednesday, May 14th. This represents a $0.82 annualized dividend and a yield of 3.40%. Kenvue's dividend payout ratio is presently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.